Partnering and collaboration is a critical element of Astra Logics' growth strategy and we welcome the opportunity to explore alliances with pharmaceutical and biotech companies that complement our expertise in drug delivery technology, and strategically align with our mission and vision.
We actively seek discovery and development partners in areas such as developing, novel targeted therapies, next generation biologics, epigenetics, immunotherapy, stem cell therapy, combination treatments and more.
Global Health Partnerships
Astra Logics is committed to improving the lives of patients worldwide and welcomes tenders from potential suppliers who can fulfill the requirements of our organization on a competitive basis, by adding value to our products and services.
With more than 80,000 molecular compounds across multiple platforms in our library, Astra Logics can offer both applicational potential and nana-medical expertise in treating neglected diseases of the developing world.
Suppliers
Astra Logics is committed to improving the lives of cancer patients and welcomes tenders from potential suppliers who can fulfill the requirements of our organization on a competitive basis and add value to our products and services.
Our procurement follows a strategic process to identify the best suppliers, and works with internal teams to ensure we get the best value in terms of quality, cost, service and delivery. We expect our suppliers to deliver innovative and sustainable solutions while operating with high ethical standards and integrity. Becoming an Astra Logics supplier implies that you adhere to fair business practices.
Please Contact Us to find out more about current partnership opportunities with Astra Logics.
IMPORTANT: Contacting Astra Logics, Inc. to request or offer to provide information relating to partnering and collaboration opportunies indicates your willingness to do business with us. It does not translate into a "Preferred Partner" status nor does it indicate pre-qualification or approval for any future project.